169 related articles for article (PubMed ID: 30849663)
1. Nanobody against the E7 oncoprotein of human papillomavirus 16.
Li S; Zhang W; Jiang K; Shan H; Shi M; Chen B; Hua Z
Mol Immunol; 2019 May; 109():12-19. PubMed ID: 30849663
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.
Accardi L; Paolini F; Mandarino A; Percario Z; Di Bonito P; Di Carlo V; Affabris E; Giorgi C; Amici C; Venuti A
Int J Cancer; 2014 Jun; 134(11):2742-7. PubMed ID: 24226851
[TBL] [Abstract][Full Text] [Related]
3. A novel intracellular nanobody against HPV16 E6 oncoprotein.
Zhang W; Shan H; Jiang K; Huang W; Li S
Clin Immunol; 2021 Apr; 225():108684. PubMed ID: 33549834
[TBL] [Abstract][Full Text] [Related]
4. Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients.
Bolhassani A; Zahedifard F; Taslimi Y; Taghikhani M; Nahavandian B; Rafati S
Indian J Med Res; 2009 Nov; 130(5):533-41. PubMed ID: 20090101
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
Donà MG; Giorgi C; Accardi L
BMC Cancer; 2007 Jan; 7():25. PubMed ID: 17266749
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
7. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
10. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
11. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.
Phaëton R; Gutierrez J; Jiang Z; Karabakhtsian RG; Albanese J; Sunkara J; Fisher DR; Goldberg GL; Dadachova E
Immunotherapy; 2015; 7(6):631-40. PubMed ID: 26098137
[TBL] [Abstract][Full Text] [Related]
12. A Genetically Modified attenuated
Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
[TBL] [Abstract][Full Text] [Related]
13. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
Park S; Park JW; Pitot HC; Lambert PF
mBio; 2016 May; 7(3):. PubMed ID: 27190216
[TBL] [Abstract][Full Text] [Related]
14. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells.
Accardi L; Donà MG; Mileo AM; Paggi MG; Federico A; Torreri P; Petrucci TC; Accardi R; Pim D; Tommasino M; Banks L; Chirullo B; Giorgi C
BMC Cancer; 2011 Jan; 11():17. PubMed ID: 21241471
[TBL] [Abstract][Full Text] [Related]
16. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.
Wang-Johanning F; Gillespie GY; Grim J; Rancourt C; Alvarez RD; Siegal GP; Curiel DT
Cancer Res; 1998 May; 58(9):1893-900. PubMed ID: 9581830
[TBL] [Abstract][Full Text] [Related]
17. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
18. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
[TBL] [Abstract][Full Text] [Related]
19. Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors.
Paolini F; Amici C; Carosi M; Bonomo C; Di Bonito P; Venuti A; Accardi L
J Exp Clin Cancer Res; 2021 Jan; 40(1):37. PubMed ID: 33485370
[TBL] [Abstract][Full Text] [Related]
20. Generation of affibody molecules specific for HPV16 E7 recognition.
Xue X; Wang B; Du W; Zhang C; Song Y; Cai Y; Cen D; Wang L; Xiong Y; Jiang P; Zhu S; Zhao KN; Zhang L
Oncotarget; 2016 Nov; 7(45):73995-74005. PubMed ID: 27659535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
